+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS



Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS



Digestive Diseases and Sciences 55(8): 2302-2308



Evidence suggests a role for small intestinal bacterial overgrowth (SIBO) in IBS. Recently, the question has arisen whether the lactulose breath test (LBT) is abnormal in IBS subjects due to overlapping GERD and proton-pump inhibitor (PPI) usage. The aim of this study was to compare the prevalence of an abnormal LBT in IBS patients either receiving or not receiving PPI therapy. Consecutive Rome I positive IBS patients referred for LBT completed a questionnaire regarding their symptoms and medication use. All subjects then underwent an LBT. The prevalence of abnormal breath test results and hydrogen production were compared based on PPI usage. Of a total of 555 (429 female) subjects, 106 (19.1%) subjects reported current PPI use. Among those on PPI, 46.2% had a positive LBT. This was not different from the 56.3% positive LBT in non-PPI subjects (OR = 0.67, CI = 0.436-1.017, P = 0.06). No differences in hydrogen parameter were seen with PPI. The average amplitude of rise (first peak) in PPI users was 28.0 +/- 35.3 ppm from baseline; in non-PPI users it was 27.5 +/- 29.1 ppm (P = 0.89). The average rise in the second peak in PPI users was 48.5 +/- 43.8 ppm from baseline; in non-PPI users, it was 49.3 +/- 37.6 ppm (P = 0.87). The time to first peak in PPI users was 56.4 +/- 23.0 min; in non-PPI users, it was 58.2 +/- 26.1 min (P = 0.58). However, among subjects receiving PPI only 7.5% had methane detection on LBT, which is significantly different from the 15.4% of subjects not taking PPI. PPI therapy does not effect hydrogen production on lactulose breath tests in IBS patients. However, there may be an effect on methane.

(PDF emailed within 0-6 h: $19.90)

Accession: 055260255

Download citation: RISBibTeXText

PMID: 19834807

DOI: 10.1007/s10620-009-1010-2


Related references

IBS subjects with methane on lactulose breath test have lower postprandial serotonin levels than subjects with hydrogen. Digestive Diseases and Sciences 49(1): 84-87, 2004

The early effect of proton pump inhibitor therapy on the accuracy of the 13C-urea breath test. Digestive and Liver Disease 37(1): 28-32, 2005

Association between chronic use of proton pump inhibitors and small- intestinal bacterial overgrowth assessed using lactulose hydrogen breath tests. Hepato-Gastroenterology 62(138): 268-272, 2015

Current or recent proton pump inhibitor therapy markedly impairs the accuracy of the [14C]urea breath test. European Journal of Gastroenterology and Hepatology 10(9): 759-764, 1998

Long-term proton pump inhibitor therapy leads to small bowel bacterial overgrowth as determined by breath hydrogen and methane excretion. Journal of Breath Research 12(3): 036006, 2017

Effects of proton pump inhibitor therapy on 13c breath test stool antigen test in h pylori effects of citric acid orange juice. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No 451, 2003

Repeatability of lactulose hydrogen breath test in subjects with normal or prolonged orocecal transit. Digestive Diseases & Sciences 33(12): 1525-1527, 1988

The effect of dose and osmolality of lactulose on the oral cecal transit time determined by the hydrogen breath test and the reproducibility of the test in normal subjects. Annals of Clinical Research 17(6): 331-333, 1985

Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test. Canadian Journal of Gastroenterology 19(6): 350-358, 2005

Orocecal transit times in healthy subjects assessed by magnet tracing and lactulose breath hydrogen test. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No M2156, 2003

The presence of constipation and methane on lactulose breath test in IBS subjects is associated with lower serotonin levels compared to hydrogen alone. American Journal of Gastroenterology 98(9 Supplement): S72, 2003

Measurement of the orocaecal transit time after an oral lactulose load--does the fasting breath hydrogen concentration affect the feasibility of the test?. Wiadomosci Lekarskie 61(4-6): 107-112, 2008

Selection of lower cutoff point of [13C]urea breath test is helpful to monitor H. pylori eradication after proton pump inhibitor-based triple therapy. Digestive Diseases and Sciences 45(7): 1330-1336, 2000

An appraisal of the fasting breath hydrogen concentration and the 10g lactulose breath hydrogen test in culture-proven small intestinal bacterial colonisation. Gastroenterology 104(4 SUPPL ): A274, 1993

Combination of lactulose hydrogen breath test with 13C-acetate breath test for diagnosing gastrointestinal motility disorders. Gastroenterology 120(5 Supplement 1): A 754, 2001